Financial Survey: MJ (OTCMKTS:MJNE) & OptimizeRx (NASDAQ:OPRX)

MJ (OTCMKTS:MJNEGet Free Report) and OptimizeRx (NASDAQ:OPRXGet Free Report) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and earnings.

Valuation & Earnings

This table compares MJ and OptimizeRx”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
MJ $360,000.00 0.00 -$5.38 million N/A N/A
OptimizeRx $92.13 million 2.03 -$17.57 million ($1.10) -9.19

MJ has higher earnings, but lower revenue than OptimizeRx.

Profitability

This table compares MJ and OptimizeRx’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
MJ N/A N/A N/A
OptimizeRx -27.41% -4.92% -3.41%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for MJ and OptimizeRx, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MJ 0 0 0 0 0.00
OptimizeRx 0 3 8 0 2.73

OptimizeRx has a consensus price target of $10.38, suggesting a potential upside of 2.62%. Given OptimizeRx’s stronger consensus rating and higher possible upside, analysts plainly believe OptimizeRx is more favorable than MJ.

Institutional & Insider Ownership

76.5% of OptimizeRx shares are held by institutional investors. 35.9% of MJ shares are held by company insiders. Comparatively, 6.1% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Risk and Volatility

MJ has a beta of -0.08, suggesting that its stock price is 108% less volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500.

Summary

OptimizeRx beats MJ on 6 of the 11 factors compared between the two stocks.

About MJ

(Get Free Report)

MJ Holdings, Inc., a cannabis holding company, engages in cultivation management, asset, and infrastructure development business in Nevada. It is also involved in production of cannabis related products; and provision of management services, dispensaries, and consulting services. The company is headquartered in Las Vegas, Nevada.

About OptimizeRx

(Get Free Report)

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

Receive News & Ratings for MJ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MJ and related companies with MarketBeat.com's FREE daily email newsletter.